← Back to Search

HPV Twitter Education Program - Narrative for Human Papillomavirus

N/A

Waitlist Available

Research Sponsored by University of Arkansas, Fayetteville

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up only at 1-month post intervention

Awards & highlights

Study Summary

This trial will examine whether Twitter messages about the HPV vaccine influence parents' decisions to vaccinate their children.

Eligible Conditions

Human Papillomavirus
Vaccine-Preventable Diseases

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in caregiver self-reported intention to vaccinate their child at 1-year follow-up from 1-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in caregiver self-reported intention to vaccinate their child at 1-year follow-up from 1-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in caregiver self-reported intention to vaccinate their child at 1-year follow-up from 1-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in caregiver self-reported HPV vaccination status of child questionnaire

Secondary outcome measures

Caregiver self-reported empathy subscale adapted from Busselle & Bilandzic (2009) and Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013).

Caregiver self-reported identification subscale adapted from Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013). Narrative versus Non-narrative: The Role of Identification, Transportation and Emotion in Reducing Health Disparities.

Caregiver self-reported transportation subscale adapted from Murphy, Frank, Chatterjee, Baezconde-Garbanati (2013). Narrative versus Non-narrative: The Role of Identification, Transportation and Emotion in Reducing Health Disparities.

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: NarrativeExperimental Treatment1 Intervention

The intervention condition will present narrative-focused messages about HPV and the HPV vaccine that includes important parent focused exemplar language and cultural norms on Twitter told through stories and characters (i.e., pseudo-parents).

Group II: Non-NarrativeActive Control1 Intervention

The non-narrative condition will present scientific-focused messages about HPV and the HPV vaccine that includes important information relayed with numbers and facts.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesOTHER

1,528 Previous Clinical Trials

10,276,251 Total Patients Enrolled

University of Arkansas, FayettevilleLead Sponsor

20 Previous Clinical Trials

1,115 Total Patients Enrolled

Thomas Jefferson UniversityOTHER

445 Previous Clinical Trials

145,114 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies still available in this research endeavor?

"Affirmative. The clinicaltrials.gov website specifies that this research is actively recruiting participants since its first post on December 13th, 2021 and most recent update on January 10th 2022. 600 individuals need to be recruited from 1 medical facility."

Answered by AI

What is the upper limit for patient enrollment in this clinical experiment?

"Affirmative. The information available on clinicaltrials.gov affirms that this trial is currently looking for participants; it was first posted on December 13th 2021 and has been updated as of January 10th 2022. Approximately 600 applicants are being sought from one site."

Answered by AI

Recent research and studies

Frontiers in Digital HealthJournal

Development of Personas to Communicate Narrative-based Information About the HPV Vaccine on Twitter

Massey, Philip M., Shawn C. Chiang, Meredith Rose, Regan M. Murray, Madeline Rockett, Elikem Togo, Ann C. Klassen, Jennifer A. Manganello, and Amy E. Leader. 2021. “Development of Personas to Communicate Narrative-based Information About the HPV Vaccine on Twitter”. Frontiers in Digital Health. Frontiers Media SA. doi:10.3389/fdgth.2021.682639.

Preventive Medicine ReportsJournal

Identifying HPV Vaccine Narrative Communication Needs Among Parents on Social Media

Massey, Philip M., Elikem Togo, Shawn C. Chiang, Ann C. Klassen, Meredith Rose, Jennifer A. Manganello, and Amy E. Leader. 2021. “Identifying HPV Vaccine Narrative Communication Needs Among Parents on Social Media”. Preventive Medicine Reports. Elsevier BV. doi:10.1016/j.pmedr.2021.101488.

Journal of Medical Internet ResearchJournal

Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics

Massey, Philip M, Matthew D Kearney, Michael K Hauer, Preethi Selvan, Emmanuel Koku, and Amy E Leader. 2020. “Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics”. Journal of Medical Internet Research. JMIR Publications Inc.. doi:10.2196/21451.

clinicaltrials.govStudy